Last reviewed · How we verify

Melatonin/experimental — Competitive Intelligence Brief

Melatonin/experimental (Melatonin/experimental) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Circadian rhythm modulator / Antioxidant. Area: Neurology / Sleep Medicine.

phase 3 Circadian rhythm modulator / Antioxidant MT1 receptor, MT2 receptor Neurology / Sleep Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Melatonin/experimental (Melatonin/experimental) — Tehran University of Medical Sciences. Melatonin is a pineal hormone that acts as a circadian rhythm regulator and antioxidant to modulate sleep-wake cycles and reduce oxidative stress.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Melatonin/experimental TARGET Melatonin/experimental Tehran University of Medical Sciences phase 3 Circadian rhythm modulator / Antioxidant MT1 receptor, MT2 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Circadian rhythm modulator / Antioxidant class)

  1. Tehran University of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Melatonin/experimental — Competitive Intelligence Brief. https://druglandscape.com/ci/melatonin-experimental. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: